S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
Log in
NYSE:STE

STERIS Stock Forecast, Price & News

$174.80
+1.81 (+1.05 %)
(As of 02/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$172.19
Now: $174.80
$176.18
50-Day Range
$172.99
MA: $186.49
$202.81
52-Week Range
$105.69
Now: $174.80
$203.90
Volume1.09 million shs
Average Volume594,277 shs
Market Capitalization$14.92 billion
P/E Ratio35.46
Dividend Yield0.92%
Beta0.59
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services. This segment offers its products and services to acute care hospitals, ambulatory surgery centers, and GI clinics. The Healthcare Specialty Services segment provides solutions and managed services, such as instrument and endoscope repair and maintenance solutions; custom process improvement consulting services; and outsourced instrument sterile processing services to acute care hospitals and other healthcare settings. The Life Sciences segment offers formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The company was founded in 1985 and is based in Dublin, Ireland.
STERIS logo

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP85915210
Phone353-1232-2000
Employees13,000
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.03 billion
Cash Flow$7.22 per share
Book Value$40.17 per share

Profitability

Net Income$407.61 million

Miscellaneous

Market Cap$14.92 billion
Next Earnings Date5/12/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

2.26 out of 5 stars

Medical Sector

29th out of 1,960 stocks

Surgical Appliances & Supplies Industry

1st out of 40 stocks

Analyst Opinion: 2.3Community Rank: 2.1Dividend Strength: 3.3Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
$174.80
+1.81 (+1.05 %)
(As of 02/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive STE News and Ratings via Email

Sign-up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











STERIS (NYSE:STE) Frequently Asked Questions

Is STERIS a buy right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for STERIS in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" STERIS stock.
View analyst ratings for STERIS
or view top-rated stocks.

What stocks does MarketBeat like better than STERIS?

Wall Street analysts have given STERIS a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but STERIS wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting STERIS?

STERIS saw a increase in short interest in January. As of January 29th, there was short interest totaling 1,220,000 shares, an increase of 43.2% from the January 14th total of 851,700 shares. Based on an average daily volume of 452,600 shares, the short-interest ratio is presently 2.7 days.
View STERIS's Short Interest
.

When is STERIS's next earnings date?

STERIS is scheduled to release its next quarterly earnings announcement on Wednesday, May 12th 2021.
View our earnings forecast for STERIS
.

How were STERIS's earnings last quarter?

STERIS plc (NYSE:STE) announced its quarterly earnings results on Tuesday, February, 2nd. The medical equipment provider reported $1.73 EPS for the quarter, topping analysts' consensus estimates of $1.52 by $0.21. The medical equipment provider earned $808.90 million during the quarter, compared to analyst estimates of $794.08 million. STERIS had a net margin of 13.97% and a trailing twelve-month return on equity of 14.44%. The firm's quarterly revenue was up 4.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.45 earnings per share.
View STERIS's earnings history
.

How has STERIS's stock price been impacted by Coronavirus?

STERIS's stock was trading at $145.25 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, STE stock has increased by 20.3% and is now trading at $174.80.
View which stocks have been most impacted by COVID-19
.

How often does STERIS pay dividends? What is the dividend yield for STERIS?

STERIS announced a quarterly dividend on Tuesday, February 2nd. Stockholders of record on Wednesday, February 24th will be given a dividend of $0.40 per share on Thursday, March 25th. This represents a $1.60 annualized dividend and a yield of 0.92%. The ex-dividend date of this dividend is Tuesday, February 23rd.
View STERIS's dividend history
.

Is STERIS a good dividend stock?

STERIS pays an annual dividend of $1.60 per share and currently has a dividend yield of 0.92%. STERIS has been increasing its dividend for 15 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of STERIS is 28.37%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, STERIS will have a dividend payout ratio of 23.32% next year. This indicates that STERIS will be able to sustain or increase its dividend.
View STERIS's dividend history.

What price target have analysts set for STE?

5 brokerages have issued 12 month price targets for STERIS's shares. Their forecasts range from $200.00 to $230.00. On average, they expect STERIS's share price to reach $213.50 in the next year. This suggests a possible upside of 22.1% from the stock's current price.
View analysts' price targets for STERIS
or view top-rated stocks among Wall Street analysts.

Who are STERIS's key executives?

STERIS's management team includes the following people:
  • Mr. Walter M. Rosebrough Jr., CEO, Pres & Director (Age 67, Pay $2.49M)
  • Mr. Michael J. Tokich, Sr. VP & CFO (Age 52, Pay $1.08M)
  • Mr. Daniel A. Carestio, Sr. VP & Chief Operating Officer (Age 48, Pay $1.09M)
  • Mr. John Adam Zangerle, Sr. VP, Gen. Counsel, Sec. (Age 54, Pay $760.33k)
  • Mr. Cary L. Majors, Sr. VP of North America Commercial Operations (Age 46, Pay $690.69k)
  • Ms. Karen L. Burton, Chief Accounting Officer, VP & Controller (Age 53)
  • Julie Winter, Sr. Director of Investor Relations and Corp. Communications
  • Mr. Sudhir K. Pahwa, Sr. VP of Infection Prevention Technologies (Age 68)
  • Stephen Norton, Sr. Director of Corp. Communications
  • Mr. Renato G. Tamaro, VP & Corp. Treasurer (Age 52)

What is Walter M. Rosebrough, Jr.'s approval rating as STERIS's CEO?

196 employees have rated STERIS CEO Walter M. Rosebrough, Jr. on Glassdoor.com. Walter M. Rosebrough, Jr. has an approval rating of 79% among STERIS's employees.

Who are some of STERIS's key competitors?

What other stocks do shareholders of STERIS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STERIS investors own include Johnson & Johnson (JNJ), The Home Depot (HD), AT&T (T), Visa (V), AbbVie (ABBV), Abbott Laboratories (ABT), Pfizer (PFE), Gilead Sciences (GILD), Mastercard (MA) and Medtronic (MDT).

What is STERIS's stock symbol?

STERIS trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

Who are STERIS's major shareholders?

STERIS's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (9.01%), WCM Investment Management LLC (7.72%), Janus Henderson Group PLC (3.81%), Northern Trust Corp (1.49%), William Blair Investment Management LLC (1.41%) and Select Equity Group L.P. (1.31%). Company insiders that own STERIS stock include Cary L Majors, Daniel A Carestio, David B Lewis, Jacqueline B Kosecoff, John Adam Zangerle, Julia Madsen, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard C Breeden, Richard Martin Steeves and Walter M Rosebrough Jr.
View institutional ownership trends for STERIS
.

Which major investors are selling STERIS stock?

STE stock was sold by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Select Equity Group L.P., Alta Capital Management LLC, Villere ST Denis J & Co. LLC, JPMorgan Chase & Co., Lazard Asset Management LLC, Nicholas Company Inc., and Frontier Capital Management Co. LLC. Company insiders that have sold STERIS company stock in the last year include Cary L Majors, Daniel A Carestio, David B Lewis, John Adam Zangerle, Julia Madsen, Karen L Burton, Mohsen Sohi, Richard C Breeden, and Walter M Rosebrough Jr.
View insider buying and selling activity for STERIS
or view top insider-selling stocks.

Which major investors are buying STERIS stock?

STE stock was bought by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., BlackRock Inc., Morgan Stanley, WCM Investment Management LLC, First Trust Advisors LP, Assenagon Asset Management S.A., Public Employees Retirement System of Ohio, and Clark Capital Management Group Inc..
View insider buying and selling activity for STERIS
or or view top insider-buying stocks.

How do I buy shares of STERIS?

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is STERIS's stock price today?

One share of STE stock can currently be purchased for approximately $174.80.

How much money does STERIS make?

STERIS has a market capitalization of $14.92 billion and generates $3.03 billion in revenue each year. The medical equipment provider earns $407.61 million in net income (profit) each year or $5.64 on an earnings per share basis.

How many employees does STERIS have?

STERIS employs 13,000 workers across the globe.

What is STERIS's official website?

The official website for STERIS is www.steris.com.

Where are STERIS's headquarters?

STERIS is headquartered at 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296.

How can I contact STERIS?

STERIS's mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The medical equipment provider can be reached via phone at 353-1232-2000 or via email at [email protected]


This page was last updated on 2/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.